Multiple Myeloma Clinical Trials Database - Free Access to 1,574 Studies
Access comprehensive clinical trial information for Multiple Myeloma through Pure Global AI's free database. This collection includes 1,574 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 328 trials are actively recruiting participants.
Research for Multiple Myeloma is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Celgene and University of Arkansas. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
Study of SYS6020 in BCMA-positive Multiple Myeloma
A Real-World Study of Bispecific Antibodies in Multiple Myeloma
Precision Medicine Study
Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma
Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma
Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
Registry of Haploidentical Hematopoietic Stem Cell Transplantation in Adult With Hematologic Disease
A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
Hypofractionation (Radiation) Trial for Multiple Myeloma
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
LI-TASTE Study: Light for Taste
A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Pure Global AI provides free access to 1,574 clinical trials studying Multiple Myeloma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Celgene, University of Arkansas, Janssen Research & Development, LLC, among others.